Imaging assessment of prostate cancer recurrence: advances in detection of local and systemic relapse.

Autor: Muglia VF; Department of Medical Images, Oncology and Hematology, Ribeirao Preto Medical School, University of Sao Paulo, Hospital Clinicas Ribeirao Preto - Av. Bandeirantes 3900. Campus Monte Alegre -USP, Sao Paulo, 14049-900, Brazil. fmuglia@fmrp.usp.br., Laschena L; Department of Radiological Sciences, Oncology and Pathology, Sapienza University, Rome, Italy., Pecoraro M; Department of Radiological Sciences, Oncology and Pathology, Sapienza University, Rome, Italy., de Lion Gouvea G; Department of Medical Images, Oncology and Hematology, Ribeirao Preto Medical School, University of Sao Paulo, Hospital Clinicas Ribeirao Preto - Av. Bandeirantes 3900. Campus Monte Alegre -USP, Sao Paulo, 14049-900, Brazil., Colli LM; Department of Medical Images, Oncology and Hematology, Ribeirao Preto Medical School, University of Sao Paulo, Hospital Clinicas Ribeirao Preto - Av. Bandeirantes 3900. Campus Monte Alegre -USP, Sao Paulo, 14049-900, Brazil., Panebianco V; Department of Radiological Sciences, Oncology and Pathology, Sapienza University, Rome, Italy.
Jazyk: angličtina
Zdroj: Abdominal radiology (New York) [Abdom Radiol (NY)] 2024 Sep 10. Date of Electronic Publication: 2024 Sep 10.
DOI: 10.1007/s00261-024-04412-7
Abstrakt: Prostate cancer (PCa) relapse, defined either by persistent PSA levels (after RP) or biochemical recurrence (BCR), is a common occurrence. The imaging evaluation of patients experiencing PCa relapse has undergone significant advancements in the past decade, notably with the introduction of new Positron Emission Tomography (PET) tracers such as Prostate-specific membrane antigen (PSMA), and the progress in functional Magnetic Resonance Imaging (MRI). This article will explore the role of traditional imaging, the evolution of MRI towards the development of the Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR) scoring system, and how next-generation imaging is enhancing diagnostic accuracy in the setting of PCa relapse, which is essential for adopting personalized strategies that may ultimately impact outcomes.
(© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: